Ask AI
ProCE Banner Series

Precision in Practice: Navigating AE Mitigation in the Era of Targeted Treatments to Elevate Clinical Outcomes for Patients With High-Risk HR+/HER2- Breast Cancer

This program covers evidence-based strategies for adverse event mitigation and treatment optimization in high-risk HR-positive/HER2-negative breast cancer, focusing on targeted therapies across early and metastatic settings. Gain practical guidance on monitoring, dose modification, and patient communication to support adherence and outcomes.

Who Should Attend

This activity is intended for nurse practitioners, physician associates, clinical nurse specialists, advanced-degree nurses, and other healthcare professionals who care for patients with breast cancer.

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to enhance learners’ knowledge, clinical competence, and confidence in the identification, prevention, and management of adverse events associated with emerging and established targeted therapies for patients with high-risk HR-positive/HER2-negative breast cancer.

Target Audience
This activity is intended for nurse practitioners, physician associates, clinical nurse specialists, advanced-degree nurses, and other healthcare professionals who care for patients with breast cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement evidence-based strategies to proactively identify, prevent, and manage adverse events associated with CDK4/6 inhibitors, oral SERDs, and PI3K/AKT-targeted therapies for patients with high-risk HR-positive/HER2-negative breast cancer in both adjuvant and metastatic settings

  • Individualize targeted therapy regimens based on patient- and disease-specific variables to optimize treatment outcomes for patients with high-risk HR-positive/HER2-negative breast cancer

  • Apply enhanced patient communication and shared-decision making skills in educating, monitoring, and supporting patients receiving targeted therapies to improve adherence and clinical outcomes

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours, including 2.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies. 

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC dba Decera Clinical Education.

Partners for Advancing Clinical Education (Partners) 2025

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191